![]() Blueprint Medicines Blueprint Medicines is a biopharmaceutical company engaged in developing therapies for allergy, inflammation, and oncology/hematology. | ||
Founding Date | Founding Date 1984 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Hyderabad, IN HQ Melbourne, AU São Paulo, BR Mississauga, CA Kunshan, CN Bogotá, CO Rueil Malmaison, FR see more | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH |
Employees | Employees 27,0486% increase | Employees 6552% increase |
Financial | ||
Revenue (est.) | Revenue (est.) ₹335.9b (FY, 2026) | Revenue (est.) $508.8m (FY, 2024) |
Cost of goods | Cost of goods ₹133.1b (FY, 2026) | Cost of goods $20.2m (FY, 2024) |
Gross profit | Gross profit ₹207.1b (FY, 2026) | Gross profit $488.7m (FY, 2024) |
Net income | Net income ₹41.6b (FY, 2026) | Net income ($67.1m) (FY, 2024) |

Blueprint Medicines is a biopharmaceutical company engaged in developing therapies for allergy, inflammation, and oncology/hematology.
View company